NAFDAC is in receipt of information regarding drugs that were declared Not of Standard Quality(NSQ) by the Central Drugs Standard Control Organization (CDSCO), India.
This declaration follows the results of analysed drug samples picked from sales/distribution points with the outcome of NSQ.
Some of the affected pharmaceutical companies were reported to have subsidiaries, partners and products in Nigeria. Below is the list of affected companies:
1. Abaris Healthcare Pvt Ltd
2. Alencure Biotech Pvt Ltd
3. Eurolife Healthcare Pvt Ltd
4. Health Biotech Ltd
5. HIGGS Healthcare
6. Kamataka Antibiotics & Pharmaceuticals Ltd (KAPL)
7. Laborate Pharmaceuticals India Ltd
8. Legend Industries
9. Martins & Brown Biosciences Pvt Ltd
10. Mascot Health Series Pvt Ltd
11. Micron Pharmaceutical
12. Orison Pharma International
13. Rivpra Formulation Pvt Ltd
14. Sai Parenterals Ltd
15. Symbiosis Pharmaceuticals Pvt Ltd
16. Syncom Formulations (India) Ltd
17. Zee Laboratories Ltd
Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322 or send an email to sf.alert@nafdac.gov.ng
0 Comments